banner

Posts tagged as: BCOV back to homepage

Brightcove IPO Rings in at $11 Brightcove IPO Rings in at $11(0)

Falling right into the expected range of $10 - $12 a share, Brightcove, Inc.’s (NASDAQ:BCOV) initial public offering if for five million shares at $11 each. Read More

OTCBB News

ecoTECH Energy Prepares for Site Construction of Eco-Industrial Complex in McBride, BC and Receives $55 Million Debt Financing(0)
Bioheart Makes Technical Breakout(0)
FrogAds Shares Rise to Signing Pamela Anderson as Spokesperson(0)
Singing Machine Reports 25 Percent Jump in Q3 Net Sales(0)
Deyu Agriculture Acquires Deep Processed Food Manufacturer Taizihu Group(0)
LTS Nutraceuticals’ BioCalth Bone and Joint Health Supplement Enters U.S. Markets(0)
read more

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Gateways

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories
Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.